Sign up to save your podcasts
Or
Share Oral Rimegepant in Adults With Migraine and Cardiovascular Risk Factors
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Oral Rimegepant in Adults With Migraine and Cardiovascular Risk Factors
Dr. Susan Hutchinson discusses her abstract, "Oral Rimegepant 75 mg is Safe and Well Tolerated in Adults With Migraine and Cardiovascular Risk Factors: Results of a Multicenter, Long-Term, Open-Label Safety Study".
You can view her abstract and others here: https://index.mirasmart.com/AAN2021/
View all episodes
By American Academy of Neurology
4.8
129129 ratings
Dr. Susan Hutchinson discusses her abstract, "Oral Rimegepant 75 mg is Safe and Well Tolerated in Adults With Migraine and Cardiovascular Risk Factors: Results of a Multicenter, Long-Term, Open-Label Safety Study".
You can view her abstract and others here: https://index.mirasmart.com/AAN2021/
More shows like Neurology Minute
View all
JAMA Editors' Summary
129 Listeners
Neurology® Podcast
285 Listeners
NEJM This Week
316 Listeners
Practical Neurology Podcast
44 Listeners
JAMA Clinical Reviews
487 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Medical News
82 Listeners
Neurology Today in 5
23 Listeners
Annals On Call Podcast
184 Listeners
Navigating Neuropsychology
341 Listeners
The Clinical Problem Solvers
508 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
321 Listeners
Neurology Exam Prep Podcast
182 Listeners
The Curious Clinicians
362 Listeners
Continuum Audio
77 Listeners